Investigative Radiology · 2007 · 298 citations · 24 references
EngineeringBiomedical EngineeringOncologyBiomedical ImagingNanomaterialsNanotechnologyCancer NanomedicineNanomedicineNanoparticle CharacterizationNanoparticle StabilityNanoparticle SynthesisTumor ImagingBlood-pool Contrast AgentsColloidal NanoparticlesNanocrystalsNanoparticle Contrast AgentsNanoparticle Imaging AgentsNanoparticle Imaging ProbesNanoparticlesX-ray Computed Tomography
OBJECTIVES: To present the pharmacokinetics and computed tomographic imaging efficacy of colloidal gold nanoparticles (AuNPs) as a blood-pool agent for x-ray computed tomography (CT). METHODS AND MATERIALS: To prepare the colloidal AuNPs, gold nanocrystals were modified using sulfhydrated polyethylene glycol (PEG). Cytotoxicity and histopathologic tests were carried out for toxicity evaluation. Six adult Balb/c mice underwent microcomputed tomography scans after injection of colloidal AuNPs (2.5 micromol Au/g body weight). Four mice with HT-1080 tumors were imaged for visualization of the tumor vasculature. RESULTS: The PEG coated colloidal AuNPs appeared as spherical nanoparticles with 38-nm diameters. The AuNPs-PEG showed a biocompatibility without toxicity in the mice. We identified a stable imaging window for visualizing the vasculature system, immediately to 24 hours after injection. Microcomputed tomography imaging using AuNPs-PEG clearly visualized the tumor vascular structures. CONCLUSION: Colloidal AuNPs show potential as a blood-pool agent for x-ray CT imaging.
24
Gold nanoparticles: a new X-ray contrast agent
James F. Hainfeld, Daniel N. Slatkin, T M Focella et al. · British Journal of Radiology · 2006 · 1.3K citations
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Giulio F. Paciotti, Lonnie D. Myer, David M. Weinreich et al. · Drug Delivery · 2004 · 1.2K citations
Pharmacy, Oncology, Pharmaceutics +17